+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mannequin-Based Simulation - Global Strategic Business Report

  • PDF Icon

    Report

  • 268 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338825

Global Mannequin-Based Simulation Market to Reach $5.6 Billion by 2030

The global market for Mannequin-Based Simulation estimated at US$2 Billion in the year 2023, is projected to reach a revised size of US$5.6 Billion by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030.

Patient Simulators, one of the segments analyzed in the report, is projected to record 13.2% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Other Product Types segment is estimated at 14.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $892.3 Million, While China is Forecast to Grow at 16.3% CAGR

The Mannequin-Based Simulation market in the U.S. is estimated at US$892.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$347.4 Million by the year 2030 trailing a CAGR of 16.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 12.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Exciting New Report Features

  • Full access to influencer engagement stats
  • Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 55 Featured)

  • Moog, Inc.
  • Laerdal Medical AS
  • Ambu A/S
  • 3B Scientific GmbH
  • Cardionics
  • DentalEZ, Inc.
  • Gaumard Scientific Co., Inc.
  • IngMar Medical
  • Kyoto Kagaku Co., Ltd.
  • Mentice AB
  • CAE Healthcare
  • Adam Rouilly Ltd.
  • Global Technologies
  • KOKEN CO., LTD.
  • LifeCast Body Simulation Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Global Economic Update
  • COVID-19 Impact on Mannequin-Based Simulation
  • Mannequin - A Prelude
  • Simulation Based Education
  • Nursing Education Embraces Simulation-based Learning in a Major Way
  • Mannequin-based Simulation: An Integral Part of Medical Simulation Market
  • Global Mannequin-based Simulation Market Set to Witness Significant Growth
  • Growth Drivers
  • Increasing Focus on Patient Safety
  • Limited Access to Live Patients Drives Market for Simulation
  • Simulation in Healthcare Enables Cost Reduction
  • Technology Revolution Drives Demand for Simulation
  • Affordability & Rising Implementation to Boost Demand
  • Developed Regions: Primary Revenue Contributors
  • Developing Regions Offer High Growth Potential for Mannequin-based Simulation
  • Patient Simulators Lead the Mannequin-based Simulation Market
  • Competition
  • Mannequin-Based Simulation - Global Key Competitors Percentage Market Share in 2022 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increase in Surgeries Augurs Well for Market Growth
  • Global Surgical Procedure Volume by Procedure Type
  • Rise in Number of Surgeries & Shortage of Surgeons Drive Use of Mannequin-based Simulation for Surgeon Education and Training
  • Surgical Backlog & Surgeon Shortages: A Harrowing Situation
  • Cancer Surgery Demand Surges Amid Surgeon Shortage
  • Mannequin-based Simulation to the Rescue
  • As the Number of Surgeries Performed Globally Increase, the Need for Well Trained Surgeons Becomes Acute, Strengthening the Business Case for Mannequin-based Simulation: Global Market for General Surgery (In US$ Billion) for Years 2018, 2020, 2022, 2024, 2026 and 2028
  • Virtual Simulation and High-Fidelity Mannequin Simulation for Recognizing Critical Events
  • High-fidelity Mannequins
  • Advanced Mannequins Imitate Human Reactions
  • Increasing Healthcare Expenditure to Foster Growth
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
  • Mannequin-based Simulation for Nursing Schools
  • Cardiology, a Promising Field for Medical Animation/Simulation
  • Simulation Benefits Interventional Cardiology
  • Mannequins Gain Traction in Military Medical Training
  • Minimally-invasive Procedures Necessitate Simulation-based Training
  • Robot-assisted Surgical Simulation Training Gaining Significance
  • Simulation Training Preferred for Cataract Surgery
  • Surgical Simulation Gets NoTable Makeover with Influx of Innovative Approaches
  • Surgical Simulation: The History & Evolution
  • Existing Surgical Simulation Models
  • Continuing Advances Pave Way for Versatile & Realistic Surgical Simulators
  • Innovations Set to Take Surgical Simulation to Next Level
  • Select Innovations
  • Learning Theories Guiding Development of Simulation-based Education
  • Areas where Under Graduate Nursing Education Simulation is Most Used
  • Virtual Simulations for UG Nursing Programs
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Mannequin-Based Simulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
  • Table 32: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
  • Table 38: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
  • Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
  • Table 53: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
  • Table 59: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Table 71: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 77: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Rest of Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: Asia-Pacific Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 89: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of World Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of World 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of World 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Moog, Inc.
  • Laerdal Medical AS
  • Ambu A/S
  • 3B Scientific GmbH
  • Cardionics
  • DentalEZ, Inc.
  • Gaumard Scientific Co., Inc.
  • IngMar Medical
  • Kyoto Kagaku Co., Ltd.
  • Mentice AB
  • CAE Healthcare
  • Adam Rouilly Ltd.
  • Global Technologies
  • KOKEN CO., LTD.
  • LifeCast Body Simulation Ltd.